Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inherited thrombophilia genes in minorities.

R Mack1, D Chowdary, D Streck

  • 1Department of Pathology and Laboratory Medicine, New Jersey Medical School/UMDNJ, Newark 07103, USA.

Genetic Testing
|January 11, 2000
PubMed
Summary

Prevalence of thrombosis-linked gene mutations like Factor V Leiden and MTHFR C677T was studied in African-Americans. While some mutations were absent, Hispanic carriers of MTHFR C677T may be more common.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Weekly biological variation of serum biochemistry analytes and fibroblast growth factor 23 in healthy cats and cats with chronic kidney disease.

The Journal of small animal practice·2025
Same author

Disparities in Opioid Pain Management for Long Bone Fractures.

Journal of racial and ethnic health disparities·2020
Same author

Treating a patient with a sacral pressure sore.

Journal of wound care·2016
Same author

Endodontic retreatment: explaining success rates and illustrated cases.

Journal of the Irish Dental Association·2003
Same author

Why endodontic retreatment is less successful than primary root canal therapy.

Journal of the Irish Dental Association·2003
Same author

Prevalence of CTLA-4 polymorphism A49G in Ashkenazi Jews.

Genetic testing·2002

Area of Science:

  • Genetics
  • Thrombosis
  • Molecular Biology

Background:

  • Genetic mutations predisposing to thrombosis, including Factor V G1691A (Factor V Leiden), Prothrombin G20210A, and Methylene tetrahydrofolate reductase (MTHFR) C677T, are well-documented in European populations.
  • Limited data exists on the prevalence of these thrombophilia-related genetic variations in minority populations, particularly those of African-American descent.

Purpose of the Study:

  • To investigate the prevalence of Factor V G1691A, Prothrombin G20210A, and MTHFR C677T mutations in a predominantly African-American population.
  • To compare the findings with existing data from European populations and assess potential ethnic disparities in thrombophilia risk factors.

Main Methods:

  • Genetic analysis of blood samples from a predominantly African-American cohort.
  • Screening for specific point mutations: Factor V G1691A, Prothrombin G20210A, and MTHFR C677T.

Main Results:

  • The Prothrombin G20210A mutation was not detected in the studied African-American population.
  • Homozygosity for the MTHFR C677T mutation was also absent in this cohort.
  • Preliminary findings suggest a potentially higher carrier rate for the MTHFR C677T mutation among Hispanic individuals within the study group compared to other reported populations.

Conclusions:

  • The Prothrombin G20210A mutation and MTHFR C677T homozygosity appear rare in the studied African-American population.
  • The MTHFR C677T mutation warrants further investigation in Hispanic populations due to potentially elevated carrier rates.
  • Understanding the ethnic prevalence of these genetic thrombophilia risk factors is crucial for accurate risk assessment and personalized medicine.

Related Experiment Videos